Mercado de metástase óssea da América do Norte – Tendências do setor e previsão para 2028

Personalize o seu relatório Personalize o seu relatório Comprar agora Comprar agora Relatório de amostra grátis Relatório de amostra grátis
Casa Healthcare North America Bone Metastasis Market
Pedido de resumo Pedido de TOC Fale com Analista Fale com o analista Comprar agora Comprar agora Consulte antes Comprar Consulte antes Relatório de amostra grátis Relatório de amostra grátis

Mercado de metástase óssea da América do Norte – Tendências do setor e previsão para 2028

  • Healthcare
  • Publish Reports
  • Aug 2021
  • North America
  • 350 Páginas
  • Número de tabelas: 135
  • Número de figuras: 55
Comprar agora Comprar agora

>Mercado de metástase óssea da América do Norte, por tipo de doença (osteoblásticos, osteoclastos), tipo (tratamento de diagnóstico), via de administração (oral, parentérica, outros), tipo de população (crianças, adultos), modo de compra ( sem balcão (OTC)) , Prescrição), Utilizador Final (Hospitais, Clínicas Especializadas, Assistência Médica Domiciliária , Blocos Operatórios Ambulatório, Outros), Canal de Distribuição (Concurso Directo, Farmácias Hospitalares, Farmácias Online, Farmácias de Retalho, Outros), Geografia (América do Norte, Europa), Por País (EUA, Canadá, México) – Tendências e previsões do setor para 2028.       

Mercado de metástase óssea da América do NorteAnálise de Mercado e Insights: Mercado de Metástase Óssea da América do Norte

Espera-se que o mercado de metástase óssea da América do Norte ganhe crescimento de mercado no período de previsão de 2021 a 2028. A Data Bridge Market Research analisa que o mercado está a crescer com um CAGR de 8,3% no período de previsão de 2021 a 2028 e prevê-se que atinja os 10.696,89 milhões de USD até 2028, contra os 5.668,98 milhões de dólares em 2020. O aumento da procura de diagnóstico precoce e preciso de doenças, a crescente prevalência do cancro é o principal motor que está a impulsionar o mercado no período de previsão.

Quando as células cancerígenas se espalham do seu local original para um osso, ocorre metástase óssea. Todos os tipos de cancro podem transformar-se em metástases ósseas. Mas o cancro da mama e o cancro da próstata têm maior probabilidade de se espalhar e são muito comuns para a doença. Pode alastrar para qualquer zona do osso, mas a coluna, os joelhos e as coxas são os mais comuns.

A metástase óssea é um tipo de cancro que pode resultar da invasão do tumor primário para o osso. É uma complicação grave do carcinoma da próstata e diferencia-se pela produção excessiva de osso osteoblástico que está associada ao nível diversificado de reabsorção óssea. Este tumor ocorre quando uma célula cancerígena se desprende de um local onde começou a crescer e se desloca para o tecido ósseo. Este é um tipo avançado de cancro.

O mercado da metástase óssea está a crescer no ano previsto por diversos motivos, como o aumento da prevalência da metástase óssea. A par disto, os fabricantes estão empenhados em atividades de I&D para o lançamento de novos produtos inovadores no mercado das metástases ósseas.
O aumento da população de doentes, o aumento dos acordos estratégicos, o aumento da I&D para lançamentos de novos produtos e o aumento das taxas de incidência de doenças de metástase óssea são os principais impulsionadores da procura do mercado de metástase óssea no período de previsão.

O relatório do mercado de metástase óssea da América do Norte fornece detalhes da quota de mercado, novos desenvolvimentos e análise do pipeline de produtos, o impacto dos participantes do mercado nacionais e localizados, analisa as oportunidades em termos de bolsas de receitas emergentes, alterações nas regulamentações de mercado, aprovações de produtos, decisões estratégicas, lançamentos de produtos, expansões geográficas e inovações tecnológicas no mercado. Para compreender a análise e o cenário do mercado, contacte-nos para obter um Analyst Brief. A nossa equipa irá ajudá-lo a criar uma solução de impacto na receita para atingir a meta desejada.  

Mercado de metástase óssea da América do NorteÂmbito do mercado de metástase óssea da América do Norte e dimensão do mercado

O mercado de metástase óssea da América do Norte está categorizado em sete segmentos notáveis ​​que se baseiam no tipo de doença, tipo, via de administração, tipo de população, modo de compra, utilizador final e canal de distribuição.

  • Com base no tipo de doença, o mercado das metástases ósseas está segmentado em osteoblásticos e osteoclastos. Em 2021, prevê-se que o segmento osteoblástico domine o mercado das metástases ósseas devido à elevada prevalência da doença.
  • Com base no tipo, o mercado das metástases ósseas está segmentado em diagnóstico e tratamento. Em 2021, prevê-se que o segmento de diagnóstico domine o mercado das metástases ósseas com o aumento das tecnologias e o avanço da capacidade de diagnóstico, como a ressonância magnética, a tomografia computorizada, entre outros.
  • Com base na via de administração, o mercado das metástases ósseas está segmentado em oral, parentérica, entre outras. Em 2021, prevê-se que o segmento parentérico domine o mercado das metástases ósseas, uma vez que atua mais rapidamente na fase posterior da doença e os resultados são melhores que os orais.
  • Com base no tipo populacional, o mercado das metástases ósseas está segmentado em crianças e adultos. Em 2021, prevê-se que o segmento dos adultos domine o mercado das metástases ósseas, uma vez que são mais propensos à doença em comparação com as crianças e necessitam de tratamento extra
  • Com base no modo de compra, o mercado de metástases ósseas é segmentado em balcão (OTC) e prescrição. Em 2021, prevê-se que o segmento de prescrição domine o mercado das metástases ósseas como nesta doença; requer diagnóstico prévio e consentimento do médico antes da prescrição.
  • Com base no utilizador final, o mercado da metástase óssea está segmentado em hospitais, clínicas especializadas, cuidados domiciliários, centros de cirurgia ambulatória, entre outros. Em 2021, espera-se que o segmento hospitalar domine o mercado das metástases ósseas, uma vez que os hospitais têm todo o diagnóstico, tratamento e instalações de saúde em comparação com outros.
  • Com base nos canais de distribuição, o mercado das metástases ósseas está segmentado em farmácias de retalho, concursos diretos, farmácias online, farmácias hospitalares, entre outros. Em 2021, espera-se que o segmento de concurso direto domine o mercado das metástases ósseas, uma vez que tem contacto direto com os fabricantes e com uma variedade de medicamentos e drogas.

Mercado de metástase óssea da América do NorteAnálise a nível de país do mercado de metástase óssea da América do Norte

North America bone metastasis market is analyzed, and market size information is provided by disease type.

The countries covered in the North America bone metastasis market report are the U.S., Canada, and Mexico.

North America is expected to dominate the market due to increasing pipeline drugs. The U.S is dominating in North America market due to rising demand for early and accurate diagnosis and product approval. Canada dominates the North America bone metastasis market due to increasing healthcare expenditures in the country. Mexico dominates the North America bone metastasis market due to the growing geriatric population and technological advancements.

 The bone metastasis market is expected to grow in the above regions with the most promising growth rate in the forecast period of 2021 to 2028 because of major companies foraying into the market, such as Amgen Inc., Siemens Medical Solutions USA, Inc. (a subsidiary of Siemens Healthcare GmbH) that are investing in developing test kits that favor results with high accuracy and novel product.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data. 

Increasing Collaboration Among Companies and Government Initiatives in North America Bone Metastasis Market is Creating New Opportunities for Players in the Bone Metastasis Market

The bone metastasis market also provides you with detailed market analysis for every country's growth in a particular industry with bone metastasis market sales, the impact of advancement in the bone metastasis market, and changes in regulatory scenarios with their support for the bone metastasis market. The data is available for the historical period 2010 to 2018. 

Competitive Landscape and Bone Metastasis Market Share Analysis

O panorama competitivo do mercado de metástase óssea fornece detalhes de um concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, localizações e instalações de produção, pontos fortes e fracos da empresa, lançamento de produtos, pipelines de testes de produtos, aprovações de produtos, patentes, largura do produto, e amplitude, domínio de aplicação, curva de segurança tecnológica. Os dados fornecidos acima estão apenas relacionados com o foco da empresa relacionado com o mercado das metástases ósseas.

As principais empresas que negoceiam no mercado norte-americano de metástases ósseas são a Amgen Inc., a Siemens Medical Solutions USA, Inc. (uma subsidiária da Siemens Healthcare GmbH), a Koninklijke Philips NV, a GENERAL ELECTRIC COMPANY, a Janssen Pharmaceuticals, Inc. da Johnson & Johnson Services, Inc.), Bayer AG, Genentech, Inc. (uma subsidiária da F. Hoffmann-La Roche Ltd), Pfizer Inc., Viatris Inc., DAIICHI SANKYO COMPANY, LIMITED, Novartis AG, Dr. Laboratories Ltd. , Fresenius Kabi AG, outros, entre outros.

Muitos lançamentos e acordos de produtos são também iniciados por empresas de todo o mundo, que também estão a acelerar o mercado das metástases ósseas.

Por exemplo,

  • Em junho de 2020, a Cipla Inc. anunciou que assinou um acordo com a Roche Products (Índia) Unip. Ltd para proporcionar um melhor acesso a medicamentos inovadores para os doentes na Índia. A Cipla Inc. assumiu a responsabilidade de comercializar e distribuir os principais medicamentos oncológicos de marca registada da Roche Pharma. Isto fortaleceu a sua parceria e melhorou o seu portfólio de produtos.
  • Em dezembro de 2020, a Pfizer Inc. anunciou a sua colaboração com a Myovant Sciences para desenvolver e comercializar o relugolix. Isto proporcionou à Pfizer Inc. uma oportunidade de comercializar o relugolix em oncologia fora dos EUA e do Canadá e aumentar as vendas em todo o mundo.

A colaboração, as joint ventures e outras estratégias do player de mercado estão a melhorar o mercado da empresa no Mercado da Metástase Óssea, o que também oferece o benefício para uma organização melhorar a sua oferta para o Mercado da Metástase Óssea.

SKU-

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Sample Image Click on image to enlarge
  • Painel interativo de análise de dados
  • Painel de análise da empresa para oportunidades de elevado potencial de crescimento
  • Acesso de analista de pesquisa para personalização e customização. consultas
  • Análise da concorrência com painel interativo
  • Últimas notícias, atualizações e atualizações Análise de tendências
  • Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência
Pedido de demonstração

Índice

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of North America bone metastasis market
    4. LIMITATIONs
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. TYPE LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market end user coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
  5. REGULATORY SCENARIO: NORTH AMERICA BONE METASTASIS MARKET
    1. REGULATORY SCENARIO IN UNITED STATES (U.S.), NORTH AMERICA
    2. REGULATORY SCENARIO IN EUROPEAN REGION
  6. Pipeline Analysis
  7. Summary write up (North America)
    1. OVERVIEW
  8. Summary write up (Europe)
    1. OVERVIEW
  9. Epidemiology
  10. PESTEL Analysis
  11. Porter's Five Forces Model
  12. Market Overview
    1. DRIVERS
      1. Rising demand for early and accurate disease diagnosis
      2. Growing prevalence of cancer
      3. Novel technology in bone metastasis diagnostics and treatment
      4. Increasing pipeline OF candidate for treatment
      5. product approval in recent past
    2. RESTRAINTS
      1. High cost of products
      2. High cost of accessories in medical devices
      3. Product recall
      4. Lack of skilled and certified professionals
    3. Opportunities
      1. Government Initiatives for cancer diagnosis and treatment
      2. growing R&D activity
      3. Acquisition and agreement by major players
    4. CHALLENGE
      1. Limitation of Products used in bone metastasis
  13. IMPACT OF COVID-19 ON NORTH AMERICA AND EUROPE BONE METASTASIS MARKET
    1. IMPACT ON PRICE
    2. IMPACT ON DEMAND
    3. IMPACT ON SUPPLY CHAIN
    4. STRATEGIC DECISION BY MANUFACTURERS
    5. CONCLUSION
  14. North America bone metastasis MARKET, BY disease type
    1. OVERVIEW
    2. OSTEOBLASTIC
    3. OSTEOCLASTIC
  15. North America bone metastasis MARKET, BY type
    1. OVERVIEW
    2. TREATMENT
      1. Treatment, BY Type
        1. MEDICATION
          1. BONE-BUILDING MEDICATION
            1. BISPHOSPHONATES
            2. ZOLEDRONIC ACID
            3. DISODIUM PAMIDRONATE
            4. SODIUM CLODRONATE
            5. OTHERS
            6. DENOSUMAB
            7. OTHERS
          2. TARGETED THERAPY
            1. TRASTUZUMAB
            2. LAROTRECTINIB
            3. OTHERS
          3. CHEMOTHERAPY
            1. DOXORUBICIN
            2. CISPLATIN
            3. CYCLOPHOSPHAMIDE
            4. IFOSFAMIDE
            5. OTHERS
          4. HORMONE THERAPY
            1. ARIMIDEX
            2. TAMOXIFEN
            3. RALOXIFENE
            4. OTHERS
          5. PAIN MEDICATION
            1. IBUPROFEN
            2. ACETAMINOPHEN
            3. DURAGESIC
            4. OTHERS
          6. STEROIDS
            1. DEXAMETHASONE
            2. PREDNISONE
            3. OTHERS
          7. OTHERS
        2. RADIATION THERAPY
          1. RADIOISOTOPES
          2. HEMI-BODY RADIATION
          3. LOCAL FIELD RADIATION
        3. SURGERY
          1. SURGERY TO STABILIZE THE BONE
          2. SURGERY TO INJECT A BONE WITH CEMENT
          3. SURGERY TO REPAIR A BROKEN BONE
      2. TREATMENT BY INDICATION
        1. PAIN
        2. HYPERCALCEMIA
        3. SPINAL CORD COMPRESSION
        4. OTHERS
    3. DIAGNOSIS
      1. BONE SCAN
      2. COMPUTED TOMOGRAPHY (CT)
      3. MAGNETIC RESONANCE IMAGING (MRI)
      4. POSITRON EMISSION TOMOGRAPHY (PET)
      5. X-RAY
      6. BIOPSY
      7. OTHERS
  16. North America bone metastasis MARKET, BY route of administration
    1. OVERVIEW
    2. PARENTERAL
      1. INTRAVENOUS
      2. SUBCUTANEOUS
      3. OTHERS
    3. ORAL
      1. TABLET
      2. CAPSULE
      3. OTHERS
    4. OTHERS
  17. North America bone metastasis MARKET, BY population type
    1. OVERVIEW
    2. ADULTS
    3. CHILDREN
  18. North America bone metastasis MARKET, BY mode of purchase
    1. OVERVIEW
    2. PRESCRIPTION
    3. OVER THE COUNTER (OTC)
  19. North America bone metastasis MARKET, BY end user
    1. OVERVIEW
    2. HOSPITAL
    3. SPECIALTY CLINIC
    4. HOME HEALTHCARE
    5. AMBULATORY SURGICAL CENTERS
    6. OTHERS
  20. North America bone metastasis MARKET, BY distribution channel
    1. OVERVIEW
    2. DIRECT TENDER
    3. HOSPITAL PHARMACIES
    4. RETAIL PHARMACIES
    5. ONLINE PHARMACIES
    6. OTHERS
  21. North America bone metastasis market, BY REGION
    1. NORTH AMERICA
      1. U.S.
      2. CANADA
      3. MEXICO
  22. north america and europe bone metastasis market: COMPANY landscape
    1. company share analysis: North america
  23. SWOT
  24. Company profiles
    1. ACCORD HEALTHCARE
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    2. AMGEN INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    3. AUROMEDICS PHARMA LLC PHARMA LLC (A SUBSIDIARY OF AUROMEDICS PHARMA LLC)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    4. BAYER AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    5. CIPLA INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    6. daiichi sankyo company, limited
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    7. DR. REDDY’S LABORATORIES LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    8. EMCURE PHARMACEUTICALS PRIVATE LIMITED
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    9. FRESENIUS KABI AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. genentech, inc. (a subsidiary of F. Hoffmann-La Roche Ltd)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    11. GENERAL ELECTRIC COMPANY
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    12. IGNUS PHARMACEUTICALS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Janssen pharmaceuticalS, inc. (A SUBSIDIARY OF johnson & johnson services, inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. koninklijke philips n.v.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    15. LANTHEUS MEDICAL IMAGING, INC. (A SUBSIDIARY OF LANTHEUS HOLDINGS, Inc.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    16. NOVARTIS AG
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    17. PFIZER INC.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    18. SAGENT PHARMACEUTICALS, INC. (A SUBSIDIARY OF NICHI-IKO PHARMACEUTICAL CO., LTD.)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    19. SIEMENS MEDICAL SOLUTIONS USA, INC. (A SUBSIDIARY OF Siemens Healthcare GmbH)
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    20. viatris inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
  25. questionnaire
  26. related reports

Lista de Tabela

TABLE 1 cost of MRI scanners of different models

TABLE 2 cost of DIFFERENT MRI COILS (BASED ON NUMBER OF CHANNELS)

TABLE 3 North America bone metastasis market, BY disease type, 2019-2028 (USD MILLION)

TABLE 4 North America osteoblastic in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 5 North America osteoclastic in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 6 North America bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 7 North America treatment in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 8 North America treatment in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 9 North America medication in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 10 North America bone-building medication in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 11 North America bisphosphonates in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 12 North America TARGeTED THERAPY in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 13 North America chemotherapy in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 14 North America hormone THERAPY in bone metastasis market, BY type 2019-2028 (USD MILLION)

TABLE 15 North America pain MEDICATION in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 16 North America STEROIDS in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 17 North America RADIATION THERAPY in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 18 North America surgery in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 19 North America treatment IN bone metastasis market, BY indication, 2019-2028 (USD MILLION)

TABLE 20 North America diagnosis in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 21 North America diagnosis in bone metastasis market, BY type, 2019-2028 (USD MILLION)

TABLE 22 North America bone metastasis market, BY route of administration, 2019-2028 (USD MILLION)

TABLE 23 North America parenteral in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 24 North America parenteral in bone metastasis market, BY route of administration, 2019-2028 (USD MILLION)

TABLE 25 North America oral in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 26 North America oral in bone metastasis market, BY route of administration, 2019-2028 (USD MILLION)

TABLE 27 North America oTHErS in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 28 North America bone metastasis market, BY population type, 2019-2028 (USD MILLION)

TABLE 29 North America adults in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 30 North America children in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 31 North America bone metastasis market, BY mode of purchase, 2019-2028 (USD MILLION)

TABLE 32 North America PRESCRIPTION in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 33 North America oVER THE COUNTER (OTC) in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 34 North America bone metastasis market, BY end user, 2019-2028 (USD MILLION)

TABLE 35 North America hospital in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 36 North America specialty clinic in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 37 North America home healthcare in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 38 North America ambulatory surgical center in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 39 North America OTHERS in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 40 North America bone metastasis market, BY distribution channel, 2019-2028 (USD MILLION)

TABLE 41 North America direct tender in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 42 North America HOSPITAL PHARMACIES in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 43 North America RETAIL PHARMACIES in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 44 North America online pharmacies in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 45 North America OTHERS in bone metastasis market, BY region, 2019-2028 (USD MILLION)

TABLE 46 North America BONE METASTASIS Market, By REGION, 2019-2028 (USD million)

TABLE 47 North America BONE METASTASIS Market, By COUNTRY, 2019-2028 (USD MILLION)

TABLE 48 North America BONE METASTASIS Market, By DISEASE type, 2019-2028 (USD MILLION)

TABLE 49 North America BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 50 North America treatment in BONE METASTASIS Market, By indication, 2019-2028 (USD MILLION)

TABLE 51 North America treatment in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 52 North America medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 53 North America bone- building medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 54 North America BISPHOSPHATES IN BONE METASTASIS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 55 North America targeted therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 56 North America chemotherapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 57 North America hormone therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 58 North America pain medications in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 59 North America steroids in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 60 North America radiation therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 61 North America surgery in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 62 North America diagnosis in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 63 North America BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 64 North America parenteral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 65 North America oral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 66 North America BONE METASTASIS Market, By population type, 2019-2028 (USD MILLION)

TABLE 67 North America BONE METASTASIS Market, By Mode of Purchase, 2019-2028 (USD MILLION)

TABLE 68 North America BONE METASTASIS Market, By end user, 2019-2028 (USD MILLION)

TABLE 69 North America BONE METASTASIS Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 70 U.S. BONE METASTASIS Market, By DISEASE type, 2019-2028 (USD MILLION)

TABLE 71 U.S. BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 72 U.S. treatment in BONE METASTASIS Market, By indication, 2019-2028 (USD MILLION)

TABLE 73 U.S. treatment in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 74 U.S. medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 75 U.S. bone- building medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 76 U.S. BISPHOSPHATES IN BONE METASTASIS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 77 U.S. targeted therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 78 U.S. chemotherapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 79 U.S. hormone therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 80 U.S. pain medications in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 81 U.S. steroids in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 82 U.S. radiation therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 83 U.S. surgery in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 84 U.S. diagnosis in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 85 U.S. BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 86 U.S. parenteral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 87 U.S. oral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 88 U.S. BONE METASTASIS Market, By population type, 2019-2028 (USD MILLION)

TABLE 89 U.S. BONE METASTASIS Market, By Mode of Purchase, 2019-2028 (USD MILLION)

TABLE 90 U.S. BONE METASTASIS Market, By end user, 2019-2028 (USD MILLION)

TABLE 91 U.S. BONE METASTASIS Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 92 CANADA BONE METASTASIS Market, By DISEASE type, 2019-2028 (USD MILLION)

TABLE 93 CANADA BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 94 CANADA treatment in BONE METASTASIS Market, By indication, 2019-2028 (USD MILLION)

TABLE 95 CANADA treatment in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 96 CANADA medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 97 CANADA bone- building medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 98 CANADA BISPHOSPHATES IN BONE METASTASIS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 99 CANADA targeted therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 100 CANADA chemotherapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 101 CANADA hormone therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 102 CANADA pain medications in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 103 CANADA steroids in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 104 CANADA radiation therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 105 CANADA surgery in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 106 CANADA diagnosis in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 107 CANADA BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 108 CANADA parenteral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 109 CANADA oral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 110 CANADA BONE METASTASIS Market, By population type, 2019-2028 (USD MILLION)

TABLE 111 CANADA BONE METASTASIS Market, By Mode of Purchase, 2019-2028 (USD MILLION)

TABLE 112 CANADA BONE METASTASIS Market, By end user, 2019-2028 (USD MILLION)

TABLE 113 CANADA BONE METASTASIS Market, By distribution channel, 2019-2028 (USD MILLION)

TABLE 114 MEXICO BONE METASTASIS Market, By DISEASE type, 2019-2028 (USD MILLION)

TABLE 115 MEXICO BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 116 MEXICO treatment in BONE METASTASIS Market, By indication, 2019-2028 (USD MILLION)

TABLE 117 MEXICO treatment in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 118 MEXICO medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 119 MEXICO bone- building medication in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 120 MEXICO BISPHOSPHATES IN BONE METASTASIS MARKET, By type, 2019-2028 (USD MILLION)

TABLE 121 MEXICO targeted therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 122 MEXICO chemotherapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 123 MEXICO hormone therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 124 MEXICO pain medications in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 125 MEXICO steroids in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 126 MEXICO radiation therapy in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 127 MEXICO surgery in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 128 MEXICO diagnosis in BONE METASTASIS Market, By type, 2019-2028 (USD MILLION)

TABLE 129 MEXICO BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 130 MEXICO parenteral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 131 MEXICO oral in BONE METASTASIS Market, By route of administration, 2019-2028 (USD MILLION)

TABLE 132 MEXICO BONE METASTASIS Market, By population type, 2019-2028 (USD MILLION)

TABLE 133 MEXICO BONE METASTASIS Market, By Mode of Purchase, 2019-2028 (USD MILLION)

TABLE 134 MEXICO BONE METASTASIS Market, By end user, 2019-2028 (USD MILLION)

TABLE 135 MEXICO BONE METASTASIS Market, By distribution channel, 2019-2028 (USD MILLION)

Lista de Figura

FIGURE 1 North America bone metastasis market: segmentation

FIGURE 2 North America bone metastasis market: data triangulation

FIGURE 3 North America bone metastasis market: DROC ANALYSIS

FIGURE 4 North America bone metastasis market: North America vs REGIONAL MARKET ANALYSIS

FIGURE 5 North America bone metastasis market: COMPANY RESEARCH ANALYSIS

FIGURE 6 North America bone metastasis market: INTERVIEW DEMOGRAPHICS

FIGURE 7 North America bone metastasis market: DBMR MARKET POSITION GRID

FIGURE 8 North America bone metastasis MARKET: MARKET end user COVERAGE GRID

FIGURE 9 North America bone metastasis market: vendor share analysis

FIGURE 10 North America bone metastasis market: SEGMENTATION

FIGURE 11 GROWING PREVALENCE OF CANCEr is expected to drive THE North America bone metastasis market IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 12 osteoblastic segment is expected to account for the largest share of the North America bone metastasis market in 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINT, OPPORTUNITIES AND CHALLENGES OF North America BONE METASTASIS Market

FIGURE 14 Number of new cancer cases in 2018, all ages

FIGURE 15 Number of new cases in 2018, in males, all ages

FIGURE 16 Number of new cases in 2018, in females, all ages

FIGURE 17 North America bone metastasis market: BY DISEASE TYPE, 2020

FIGURE 18 North America bone metastasis market: BY DISEASE TYPE, 2021-2028 (USD million)

FIGURE 19 North America bone metastasis market: BY DISEASE TYPE, CAGR (2021-2028)

FIGURE 20 North America bone metastasis market: BY DISEASE TYPE, LIFELINE CURVE

FIGURE 21 North America bone metastasis market: BY TYPE, 2020

FIGURE 22 North America bone metastasis market: BY TYPE, 2021-2028 (USD million)

FIGURE 23 North America bone metastasis market: BY TYPE, CAGR (2021-2028)

FIGURE 24 North America bone metastasis market: BY TYPE, LIFELINE CURVE

FIGURE 25 North America bone metastasis market: BY ROUTE OF ADMINISTRATION, 2020

FIGURE 26 North America bone metastasis market: BY ROUTE OF ADMINISTRATION, 2021-2028 (USD Million)

FIGURE 27 North America bone metastasis market: BY ROUTE OF ADMINISTRATION, CAGR (2021-2028)

FIGURE 28 North America bone metastasis market: BY ROUTE OF ADMINISTRATION, LIFELINE CURVE

FIGURE 29 North America bone metastasis market: BY POPULATION TYPE, 2020

FIGURE 30 North America bone metastasis market: BY POPULATION TYPE, 2021-2028 (USD million)

FIGURE 31 North America bone metastasis market: BY POPULATION TYPE, CAGR (2021-2028)

FIGURE 32 North America bone metastasis market: BY POPULATION TYPE, LIFELINE CURVE

FIGURE 33 North America bone metastasis market: BY MODE OF PURCHASE, 2020

FIGURE 34 North America bone metastasis market: BY MODE OF PURCHASE, 2021-2028 (USD Million)

FIGURE 35 North America bone metastasis market: BY MODE OF PURCHASE, CAGR (2021-2028)

FIGURE 36 North America bone metastasis market: BY MODE OF PURCHASE, LIFELINE CURVE

FIGURE 37 North America bone metastasis market: BY END USER, 2020

FIGURE 38 North America bone metastasis market: BY END USER, 2021-2028 (USD million)

FIGURE 39 North America bone metastasis market: BY END USER, CAGR (2021-2028)

FIGURE 40 North America bone metastasis market: BY END USER, LIFELINE CURVE

FIGURE 41 North America bone metastasis market: BY DISTRIBUTION CHANNEL, 2020

FIGURE 42 North America bone metastasis market: BY DISTRIBUTION CHANNEL, 2021-2028 (USD Million)

FIGURE 43 North America bone metastasis market: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 44 North America bone metastasis market: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 45 North America bone metastasis market: SNAPSHOT (2020)

FIGURE 46 North America bone metastasis market: BY REGION (2020)

FIGURE 47 North America bone metastasis market: BY REGION (2021 & 2028)

FIGURE 48 North America bone metastasis market: BY REGION (2020 & 2028)

FIGURE 49 North America bone metastasis market: BY DISEASE TYPE (2021-2028)

FIGURE 50 NORTH AMERICA bone metastasis market: SNAPSHOT (2020)

FIGURE 51 NORTH AMERICA bone metastasis market: BY COUNTRY (2020)

FIGURE 52 NORTH AMERICA bone metastasis market: BY COUNTRY (2021 & 2028)

FIGURE 53 NORTH AMERICA bone metastasis market: BY COUNTRY (2020 & 2028)

FIGURE 54 NORTH AMERICA bone metastasis market: BY DISEASE TYPE (2021-2028)

FIGURE 55 North America bone metastasis Market: company share 2020 (%)

View Detailed Information Right Arrow

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados ​​e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis ​​de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

North America Bone Metastasis Market to grow at a CAGR 8.3% by forecast 2028.
North America Bone Metastasis Market value to reach USD 10,696.89 million by forecast 2028.
The countries covered in the North America bone metastasis market report are the U.S., Canada, and Mexico.
The major companies which are dealing in the North America Bone Metastasis Market are Amgen Inc., Siemens Medical Solutions USA, Inc. (a subsidiary of Siemens Healthcare GmbH), Koninklijke Philips N.V., GENERAL ELECTRIC COMPANY, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), Bayer AG, Genentech, Inc. (a subsidiary of F. Hoffmann-La Roche Ltd), Pfizer Inc., Viatris Inc., DAIICHI SANKYO COMPANY, LIMITED, Novartis AG, Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Others.

Navegue pelas páginas relacionadas

Banner